Huanhuan Luo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Huanhuan Luo has a total of 102 co-authors. Here are the top co-authors by number of shared publications:
Yi Luo
State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangzhou University of Chinese Medicine, Guangzhou, China
8 shared publications- Song Chen
Guangzhou University of Chinese Medicine
6 shared publications Yalan Wu
State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangzhou University of Chinese Medicine, Guangzhou, China
6 shared publicationsYao Wang
State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China
6 shared publicationsYuhua Zheng
School of Basic Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China
5 shared publicationsJianbang Tang
Zhongshan Hospital of Traditional Chinese Medicine Affiliated to Guangzhou University of Chinese Medicine, Zhongshan, China
4 shared publications
Latest Publications
- Open Access
- 18 November 2026
- Published by Springer Nature in Research Square
Association of EASO-based obesity level with sleep patterns and the risk of all-cause and cardiovascular mortality
Background/Objectives The EASO framework provides a clinical staging system for obesity, but its prognostic utility relative to BMI and interaction with sleep patterns regarding mortality remain understudied. This study evaluated the independent and joint associations of EASO- and BMI-defined obesity and sleep patterns with cardiovascular and all-cause mortality, and quantified the mediating role of sleep. Subjects/Methods This prospective cohort study included 408 453 UK Biobank adults. Obesity was classified using EASO stages and BMI categories. Sleep patterns were assessed via a composite score from five self-reported dimensions. Multivariable Cox models estimated hazard ratios, and mediation analysis quantified sleep's mediating role. Results During a median follow-up of 13.02 years, 34 146 all-cause and 6 991 cardiovascular deaths occurred. Both EASO- and BMI-defined obesity were independently associated with higher mortality risks. BMI-defined obesity yielded slightly larger relative risks. Participants with both obesity and adverse sleep patterns exhibited the highest mortality risk. Sleep patterns mediated 6.9% (95% CI, 3.7%–12.4%: p < 0.001) and 15.9% (95% CI, 9.2%–26.1%: p < 0.001) of the obesity–cardiovascular and obesity–all-cause mortality associations, respectively. Conclusions The EASO framework complements BMI in stratifying mortality risk. Sleep patterns partially mediate the obesity–mortality association, supporting sleep assessment and interventions in obesity risk-stratification strategies.
- 18 November 2026
- Published by Springer Nature in Research Square
Open AccessAssociation of EASO-based obesity level with sleep patterns and the risk of all-cause and cardiovascular mortality
Background/Objectives The EASO framework provides a clinical staging system for obesity, but its prognostic utility relative to BMI and interaction with sleep patterns regarding mortality remain understudied. This study evaluated the independent and joint associations of EASO- and BMI-defined obesity and sleep patterns with cardiovascular and all-cause mortality, and quantified the mediating role of sleep. Subjects/Methods This prospective cohort study included 408 453 UK Biobank adults. Obesity was classified using EASO stages and BMI categories. Sleep patterns were assessed via a composite score from five self-reported dimensions. Multivariable Cox models estimated hazard ratios, and mediation analysis quantified sleep's mediating role. Results During a median follow-up of 13.02 years, 34 146 all-cause and 6 991 cardiovascular deaths occurred. Both EASO- and BMI-defined obesity were independently associated with higher mortality risks. BMI-defined obesity yielded slightly larger relative risks. Participants with both obesity and adverse sleep patterns exhibited the highest mortality risk. Sleep patterns mediated 6.9% (95% CI, 3.7%–12.4%: p < 0.001) and 15.9% (95% CI, 9.2%–26.1%: p < 0.001) of the obesity–cardiovascular and obesity–all-cause mortality associations, respectively. Conclusions The EASO framework complements BMI in stratifying mortality risk. Sleep patterns partially mediate the obesity–mortality association, supporting sleep assessment and interventions in obesity risk-stratification strategies.
- Open Access
- 15 August 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 9811
DUSP4 promotes anti-tumor CD8+ T cell function and boosts CAR-T cell efficacy in mouse colorectal cancer
- 15 August 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 9811
Open AccessDUSP4 promotes anti-tumor CD8+ T cell function and boosts CAR-T cell efficacy in mouse colorectal cancer
- Open Access
- 19 September 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1535527
DEFA5-producing CD4+ T cells in the intestines of atopic dermatitis patients play an important role in the development of AD-associated intestinal inflammation
Rationale: Atopic dermatitis (AD) is associated with various gastrointestinal symptoms, yet the underlying mechanisms remain poorly understood. This study aimed to investigate intraepithelial lymphocytes (IELs) in the intestines of AD patients and their potential contribution to intestinal inflammation.Methods: Single-cell RNA sequencing was utilized to analyze the immune cell composition in the ileum of adult AD patients with severe symptoms. Laser confocal microscopy, Western blot, polymerase chain reaction and adoptive T cell transfer experiments were carried out to investigate the phenotypes of IELs and contribution of CD4+ IELs in intestinal inflammation and barrier function.Results: A distinct group of DEFA5-expressing CD4+ T cells in the small intestine of AD patients was identified. These cells were enriched in tissue resident memory T cells (Trm). Peroxisome proliferator-activated receptor (PPAR) was found to be important for the function of DEFA5-expression CD4+ IELs. In an AD mouse model, an increase in DEFA5-expressing CD4+ IELs was observed compared to control, and these cells contributed to the development of intestinal inflammation and impaired intestinal barrier function.Conclusions: AD is linked to an increase in intestinal DEFA5-expressing CD4+ IELs, which may play an important role in mediating intestinal inflammation. This suggests that the DEFA5-expressing CD4+ IELs could be a potential therapeutic target for managing gastrointestinal symptoms in AD patients.
- 19 September 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1535527
Open AccessDEFA5-producing CD4+ T cells in the intestines of atopic dermatitis patients play an important role in the development of AD-associated intestinal inflammation
Rationale: Atopic dermatitis (AD) is associated with various gastrointestinal symptoms, yet the underlying mechanisms remain poorly understood. This study aimed to investigate intraepithelial lymphocytes (IELs) in the intestines of AD patients and their potential contribution to intestinal inflammation.Methods: Single-cell RNA sequencing was utilized to analyze the immune cell composition in the ileum of adult AD patients with severe symptoms. Laser confocal microscopy, Western blot, polymerase chain reaction and adoptive T cell transfer experiments were carried out to investigate the phenotypes of IELs and contribution of CD4+ IELs in intestinal inflammation and barrier function.Results: A distinct group of DEFA5-expressing CD4+ T cells in the small intestine of AD patients was identified. These cells were enriched in tissue resident memory T cells (Trm). Peroxisome proliferator-activated receptor (PPAR) was found to be important for the function of DEFA5-expression CD4+ IELs. In an AD mouse model, an increase in DEFA5-expressing CD4+ IELs was observed compared to control, and these cells contributed to the development of intestinal inflammation and impaired intestinal barrier function.Conclusions: AD is linked to an increase in intestinal DEFA5-expressing CD4+ IELs, which may play an important role in mediating intestinal inflammation. This suggests that the DEFA5-expressing CD4+ IELs could be a potential therapeutic target for managing gastrointestinal symptoms in AD patients.
- Open Access
- 27 August 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1625609
High humidity environment increases FBG by impairing the intestinal barrier
Introduction: Climate and environmental changes pose significant threats to human metabolic health; however, the specific effects of individual environmental factors on metabolic diseases remain poorly understood. This study aimed to investigate the impact of a high humidity environment (HH) on fasting blood glucose (FBG), intestinal barrier integrity, and gut microbiota composition.Methods: We analyzed clinical samples collected during HH exposure and performed a controlled male mouse experiment. FBG and hormone levels were assessed, and intestinal barrier integrity was evaluated using western blot and immunofluorescence staining. Gut microbiota composition was profiled via 16S rDNA sequencing. Mechanistic insights were obtained through fecal microbiota transplantation (FMT), Mendelian randomization (MR) analysis, and metabolomic profiling. An antibiotic cocktail (ABX) intervention was applied to determine the reversibility of HH-induced effects.Results: Clinical samples collected under HH conditions showed elevated FBG, increased glucagon (GC) levels, impaired intestinal barrier function, and decreased serum gamma-aminobutyric acid (GABA) concentrations. 16S rDNA sequencing revealed increased abundances of Alistipes, Parabacteroides, and Akkermansia. Metabolomic analysis demonstrated reduced serum GABA levels, which correlated with intestinal barrier disruption and activation of the MDP-NOD2 pathway in pancreatic β-cells. HH exposure also downregulated GAD67 expression, reducing GABA synthesis and leading to enhanced GC secretion from islet α-cells. FMT suggested that gut microbiota alterations mediated HH-induced FBG elevation. ABX treatment effectively reversed these metabolic and microbial changes.Discussion: Our findings demonstrate that a high humidity environment disrupts gut microbiota homeostasis, impairs the intestinal barrier, and reduces GABA synthesis in pancreatic β-cells, thereby promoting the development of type 2 diabetes mellitus (T2DM).
- 27 August 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1625609
Open AccessHigh humidity environment increases FBG by impairing the intestinal barrier
Introduction: Climate and environmental changes pose significant threats to human metabolic health; however, the specific effects of individual environmental factors on metabolic diseases remain poorly understood. This study aimed to investigate the impact of a high humidity environment (HH) on fasting blood glucose (FBG), intestinal barrier integrity, and gut microbiota composition.Methods: We analyzed clinical samples collected during HH exposure and performed a controlled male mouse experiment. FBG and hormone levels were assessed, and intestinal barrier integrity was evaluated using western blot and immunofluorescence staining. Gut microbiota composition was profiled via 16S rDNA sequencing. Mechanistic insights were obtained through fecal microbiota transplantation (FMT), Mendelian randomization (MR) analysis, and metabolomic profiling. An antibiotic cocktail (ABX) intervention was applied to determine the reversibility of HH-induced effects.Results: Clinical samples collected under HH conditions showed elevated FBG, increased glucagon (GC) levels, impaired intestinal barrier function, and decreased serum gamma-aminobutyric acid (GABA) concentrations. 16S rDNA sequencing revealed increased abundances of Alistipes, Parabacteroides, and Akkermansia. Metabolomic analysis demonstrated reduced serum GABA levels, which correlated with intestinal barrier disruption and activation of the MDP-NOD2 pathway in pancreatic β-cells. HH exposure also downregulated GAD67 expression, reducing GABA synthesis and leading to enhanced GC secretion from islet α-cells. FMT suggested that gut microbiota alterations mediated HH-induced FBG elevation. ABX treatment effectively reversed these metabolic and microbial changes.Discussion: Our findings demonstrate that a high humidity environment disrupts gut microbiota homeostasis, impairs the intestinal barrier, and reduces GABA synthesis in pancreatic β-cells, thereby promoting the development of type 2 diabetes mellitus (T2DM).
- Open Access
- 18 June 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1563602
Short-term exposure to a high-humidity environment triggers intestinal inflammation via AQP3
Background: With the increasing greenhouse effect, there is growing concern about the correlation between the humid environment and the incidence of various diseases. A high-humidity environment may cause intestinal inflammation through bacterial colonization or contamination of water. Aquaporin-3 (AQP3) plays an important role in maintaining intestinal water transport, permeability, fluid secretion, and absorption homeostasis. This paper explored the effects of short-term exposure to a high-humidity environment on intestinal health.Methods: To explore the effects of a high-humidity environment on the intestine, we kept wild-type mice and Aqp3 knockout (Aqp3-/-) mice in an artificial climatic box with 90(± 5) % humidity setting for a fortnight and recorded their body weights, food intake, water intake, and fur changes during the experiment. On the fourteenth day, colon tissues were collected to detect the expression of intestinal inflammatory factors, glutathione (GSH), malondialdehyde (MDA), water evaporator proteins (AQPs), and intestinal pathological changes by polymerase chain reaction (PCR), Western blotting analysis, and histopathological analysis.Results: The results showed that mice with short-term exposure to a high-humidity environment showed a significant increase in the expression of AQP3 and a significant decrease in the expression of AQP4 in the colon, and the TLR4/NF-κb/IL-6 pathway was activated. In Aqp3-/- mice, their colonic GSH expression was increased, MDA expression was decreased, and intestinal TLR4/NF-κb/IL-6 expressions were also decreased.Conclusions: This study demonstrated the high-humidity environment induces an intestinal inflammatory response through AQP3, providing persuasive evidence for the pathogenesis of environmentally related diseases.
- 18 June 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1563602
Open AccessShort-term exposure to a high-humidity environment triggers intestinal inflammation via AQP3
Background: With the increasing greenhouse effect, there is growing concern about the correlation between the humid environment and the incidence of various diseases. A high-humidity environment may cause intestinal inflammation through bacterial colonization or contamination of water. Aquaporin-3 (AQP3) plays an important role in maintaining intestinal water transport, permeability, fluid secretion, and absorption homeostasis. This paper explored the effects of short-term exposure to a high-humidity environment on intestinal health.Methods: To explore the effects of a high-humidity environment on the intestine, we kept wild-type mice and Aqp3 knockout (Aqp3-/-) mice in an artificial climatic box with 90(± 5) % humidity setting for a fortnight and recorded their body weights, food intake, water intake, and fur changes during the experiment. On the fourteenth day, colon tissues were collected to detect the expression of intestinal inflammatory factors, glutathione (GSH), malondialdehyde (MDA), water evaporator proteins (AQPs), and intestinal pathological changes by polymerase chain reaction (PCR), Western blotting analysis, and histopathological analysis.Results: The results showed that mice with short-term exposure to a high-humidity environment showed a significant increase in the expression of AQP3 and a significant decrease in the expression of AQP4 in the colon, and the TLR4/NF-κb/IL-6 pathway was activated. In Aqp3-/- mice, their colonic GSH expression was increased, MDA expression was decreased, and intestinal TLR4/NF-κb/IL-6 expressions were also decreased.Conclusions: This study demonstrated the high-humidity environment induces an intestinal inflammatory response through AQP3, providing persuasive evidence for the pathogenesis of environmentally related diseases.
- Open Access
- 26 April 2025
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 23 (1) , 1-15
Causal effect of gut microbiota on the risk of cancer and potential mediation by inflammatory proteins
While growing evidence highlights the role of gut microbiota and inflammatory proteins in cancer, with cancer-related inflammation now considered the seventh hallmark of cancer, the direct causal relationships between specific microbiota, cancer, and the potential mediating effects of inflammatory proteins have not been fully established. We employed Mendelian randomization (MR) to assess the causal relationships between gut microbiota, inflammatory proteins, and eighteen distinct cancers using data from extensive genome-wide association studies (GWAS). The primary statistical method utilized was inverse variance weighting (IVW). We also investigated whether inflammatory proteins could mediate the effects of gut microbiota on cancer development. Our findings revealed 42 positive and 49 inverse causal impacts of gut microbiota on cancer risk (P < 0.05). Additionally, we identified 32 positive and 28 inverse causal relationships between inflammatory proteins and cancer risk. Moreover, genus Collinsella decreased the risk of lung cancer by decreasing levels of T-cell surface glycoprotein CD5 (mediating effect = 16.667%), while genus Ruminococcaceae UCG005 increased the risk of mesothelioma by increasing levels of CCL4 (mediating effect = 5.134%). Our study provides evidence for a causal association between gut microbiota, inflammatory proteins, and eighteen different cancer types. Notably, the T-cell surface glycoprotein CD5 and CCL4 were identified as mediators linking the genus Collinsella with lung cancer and the genus Ruminococcaceae UCG005 with mesothelioma, respectively.
- 26 April 2025
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 23 (1) , 1-15
Open AccessCausal effect of gut microbiota on the risk of cancer and potential mediation by inflammatory proteins
While growing evidence highlights the role of gut microbiota and inflammatory proteins in cancer, with cancer-related inflammation now considered the seventh hallmark of cancer, the direct causal relationships between specific microbiota, cancer, and the potential mediating effects of inflammatory proteins have not been fully established. We employed Mendelian randomization (MR) to assess the causal relationships between gut microbiota, inflammatory proteins, and eighteen distinct cancers using data from extensive genome-wide association studies (GWAS). The primary statistical method utilized was inverse variance weighting (IVW). We also investigated whether inflammatory proteins could mediate the effects of gut microbiota on cancer development. Our findings revealed 42 positive and 49 inverse causal impacts of gut microbiota on cancer risk (P < 0.05). Additionally, we identified 32 positive and 28 inverse causal relationships between inflammatory proteins and cancer risk. Moreover, genus Collinsella decreased the risk of lung cancer by decreasing levels of T-cell surface glycoprotein CD5 (mediating effect = 16.667%), while genus Ruminococcaceae UCG005 increased the risk of mesothelioma by increasing levels of CCL4 (mediating effect = 5.134%). Our study provides evidence for a causal association between gut microbiota, inflammatory proteins, and eighteen different cancer types. Notably, the T-cell surface glycoprotein CD5 and CCL4 were identified as mediators linking the genus Collinsella with lung cancer and the genus Ruminococcaceae UCG005 with mesothelioma, respectively.
- 23 April 2025
- Published by Springer Nature in Acta Pharmacologica Sinica
- Vol. 46 (10) , 2751-2764
Fangchinoline-mediated autophagy inhibition amplifies antigen presentation and PD-1 blockade efficacy in lung cancer
Cancer cells frequently exhibit MHC-I deficiency, impairing immune-mediated cytotoxicity even in the presence of PD-1 checkpoint inhibition. To date, no clinically approved therapies exist that can upregulate MHC-I expression to boost immune responses against cancer cells. Emerging evidence has shown that autophagy plays a role in MHC-I molecule degradation, contributing to reduced recognition of cancer cells by CD8+ T cells. We previously report that fangchinoline, a bisbenzylisoquinoline alkaloid derived from Chinese herb, is a novel autophagy inhibitor with an adjuvant of chemotherapy against lung cancer. In this study we investigated the modulatory effects of PD-1 blockade combined with fangchinoline on CD8+ T cells within the tumor microenvironment of lung cancer. We showed an inverse correlation between elevated autophagic activity and decreased MHC-I surface expression—a phenomenon often associated with poor clinical efficacies—in various human lung cancer cell lines (NCI-H1299, NCI-H1975, A549, NCI-H1650 and NCI-H446) compared with normal bronchial epithelial cells lung cancer. Knockdown of ATG4 and ATG5 resulted in increased MHC-I expression and enhanced tumor antigen presentation in NCI-H1975, NCI-H1299 and A549 cells. As autophagy receptors were crucial for transporting proteins to autophagosomes for degradation, we sequentially silenced various autophagy receptors and found that NDP52 knockdown specifically restored MHC-I expression, suggesting that NDP52-mediated autophagy might contribute to MHC-I degradation, and autophagy inhibition might enhance immune-mediated cancer cell death. We showed that pretreatment of LLC-OVA cells with the autophagy inhibitor fangchinoline (1.25, 2.5, 5 μM) followed by coculture with CD8+ T cells, dose-dependently enhanced immune killing. In both in vitro and in vivo experiments, we showed that fangchinoline combined with anti-PD-1 therapy significantly increased CD8+ T cell–mediated cytotoxicity. In conclusion, this study highlights NDP52 as a key autophagy receptor involved in MHC-I degradation and provides a new insight into tumor immune evasion. Combining autophagy inhibition with immunotherapy may be a promising therapeutic strategy for anticancer immunity enhancement.
- 23 April 2025
- Published by Springer Nature in Acta Pharmacologica Sinica
- Vol. 46 (10) , 2751-2764
Fangchinoline-mediated autophagy inhibition amplifies antigen presentation and PD-1 blockade efficacy in lung cancer
Cancer cells frequently exhibit MHC-I deficiency, impairing immune-mediated cytotoxicity even in the presence of PD-1 checkpoint inhibition. To date, no clinically approved therapies exist that can upregulate MHC-I expression to boost immune responses against cancer cells. Emerging evidence has shown that autophagy plays a role in MHC-I molecule degradation, contributing to reduced recognition of cancer cells by CD8+ T cells. We previously report that fangchinoline, a bisbenzylisoquinoline alkaloid derived from Chinese herb, is a novel autophagy inhibitor with an adjuvant of chemotherapy against lung cancer. In this study we investigated the modulatory effects of PD-1 blockade combined with fangchinoline on CD8+ T cells within the tumor microenvironment of lung cancer. We showed an inverse correlation between elevated autophagic activity and decreased MHC-I surface expression—a phenomenon often associated with poor clinical efficacies—in various human lung cancer cell lines (NCI-H1299, NCI-H1975, A549, NCI-H1650 and NCI-H446) compared with normal bronchial epithelial cells lung cancer. Knockdown of ATG4 and ATG5 resulted in increased MHC-I expression and enhanced tumor antigen presentation in NCI-H1975, NCI-H1299 and A549 cells. As autophagy receptors were crucial for transporting proteins to autophagosomes for degradation, we sequentially silenced various autophagy receptors and found that NDP52 knockdown specifically restored MHC-I expression, suggesting that NDP52-mediated autophagy might contribute to MHC-I degradation, and autophagy inhibition might enhance immune-mediated cancer cell death. We showed that pretreatment of LLC-OVA cells with the autophagy inhibitor fangchinoline (1.25, 2.5, 5 μM) followed by coculture with CD8+ T cells, dose-dependently enhanced immune killing. In both in vitro and in vivo experiments, we showed that fangchinoline combined with anti-PD-1 therapy significantly increased CD8+ T cell–mediated cytotoxicity. In conclusion, this study highlights NDP52 as a key autophagy receptor involved in MHC-I degradation and provides a new insight into tumor immune evasion. Combining autophagy inhibition with immunotherapy may be a promising therapeutic strategy for anticancer immunity enhancement.
- Open Access
- 16 January 2025
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 290, 117746
Exposure to high-temperature and high-humidity environments associated with cardiovascular mortality
- 16 January 2025
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 290, 117746
Open AccessExposure to high-temperature and high-humidity environments associated with cardiovascular mortality
- Open Access
- 1 July 2024
- Published by KEAI Publishing in Genes & Diseases
- Vol. 11 (4) , 101029
Aquaporin-3 promotes proliferation and inflammation in hepatocellular carcinoma
- 1 July 2024
- Published by KEAI Publishing in Genes & Diseases
- Vol. 11 (4) , 101029
Open AccessAquaporin-3 promotes proliferation and inflammation in hepatocellular carcinoma
- Open Access
- 2 May 2024
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1367053
Intestinal microflora promotes Th2-mediated immunity through NLRP3 in damp and heat environments
Background: With the worsening of the greenhouse effect, the correlation between the damp-heat environment (DH) and the incidence of various diseases has gained increasing attention. Previous studies have demonstrated that DH can lead to intestinal disorders, enteritis, and an up-regulation of NOD-like receptor protein 3 (NLRP3). However, the mechanism of NLRP3 in this process remains unclear.Methods: We established a DH animal model to observe the impact of a high temperature and humidity environment on the mice. We sequenced the 16S rRNA of mouse feces, and the RNA transcriptome of intestinal tissue, as well as the levels of cytokines including interferon (IFN)-γ and interleukin (IL)-4 in serum.Results: Our results indicate that the intestinal macrophage infiltration and the expression of inflammatory genes were increased in mice challenged with DH for 14 days, while the M2 macrophages were decreased in Nlrp3-/- mice. The alpha diversity of intestinal bacteria in Nlrp3-/- mice was significantly higher than that in control mice, including an up-regulation of the Firmicutes/Bacteroidetes ratio. Transcriptomic analysis revealed 307 differentially expressed genes were decreased in Nlrp3-/- mice compared with control mice, which was related to humoral immune response, complement activation, phagocytic recognition, malaria and inflammatory bowel disease. The ratio of IFN-γ/IL-4 was decreased in control mice but increased in Nlrp3-/- mice.Conclusions: Our study found that the inflammation induced by DH promotes Th2-mediated immunity via NLRP3, which is closely related to the disruption of intestinal flora.
- 2 May 2024
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1367053
Open AccessIntestinal microflora promotes Th2-mediated immunity through NLRP3 in damp and heat environments
Background: With the worsening of the greenhouse effect, the correlation between the damp-heat environment (DH) and the incidence of various diseases has gained increasing attention. Previous studies have demonstrated that DH can lead to intestinal disorders, enteritis, and an up-regulation of NOD-like receptor protein 3 (NLRP3). However, the mechanism of NLRP3 in this process remains unclear.Methods: We established a DH animal model to observe the impact of a high temperature and humidity environment on the mice. We sequenced the 16S rRNA of mouse feces, and the RNA transcriptome of intestinal tissue, as well as the levels of cytokines including interferon (IFN)-γ and interleukin (IL)-4 in serum.Results: Our results indicate that the intestinal macrophage infiltration and the expression of inflammatory genes were increased in mice challenged with DH for 14 days, while the M2 macrophages were decreased in Nlrp3-/- mice. The alpha diversity of intestinal bacteria in Nlrp3-/- mice was significantly higher than that in control mice, including an up-regulation of the Firmicutes/Bacteroidetes ratio. Transcriptomic analysis revealed 307 differentially expressed genes were decreased in Nlrp3-/- mice compared with control mice, which was related to humoral immune response, complement activation, phagocytic recognition, malaria and inflammatory bowel disease. The ratio of IFN-γ/IL-4 was decreased in control mice but increased in Nlrp3-/- mice.Conclusions: Our study found that the inflammation induced by DH promotes Th2-mediated immunity via NLRP3, which is closely related to the disruption of intestinal flora.